NCT00000684View on ClinicalTrials.gov

Continuous High-Dose Intravenous Dextran Sulfate in Human Immunodeficiency Virus-Infected Individuals

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

Not specified

Study Completion Date

April 30, 1991

Conditions
HIV Infections
Interventions
DRUG

Dextran sulfate

Trial Locations (1)

21287

Johns Hopkins Adult AIDS CRS, Baltimore

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000684 - Continuous High-Dose Intravenous Dextran Sulfate in Human Immunodeficiency Virus-Infected Individuals | Biotech Hunter | Biotech Hunter